Bradykinin antagonist quinolines

Details Bradykinin antagonist quinolines Bradykinin antagonist quinolines

1994-04-26

1996-10-08

Grumbling, Matthew V.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514312, 514313, 514314, 5142282, 5142355, 514253, 514259, 514260, 544 62, 544128, 544363, 546171, 546178, 546153, 546157, C07D21502, C07D23974, A61K 3147, A61K 31505

Patent

active

055631622

ABSTRACT:
This invention relates to new heterocyclic compounds and pharmaceutically acceptable salts thereof. More particularly, this invention relates to new heterocyclic compounds and salts thereof which display bradykinin antagonist activity, to processes for preparing these compounds, to a pharmaceutical composition comprising these compounds, and to methods of using same in the prevention and/or the treatment of bradykinin- or bradykinin analogue-mediated diseases such as allergy, inflammation, autoimmune disease, shock, pain, or the like, in human beings or in animals.

REFERENCES:
patent: 3682927 (1972-08-01), Carissimi et al.
patent: 4749406 (1988-06-01), Martin
patent: 5006534 (1991-04-01), Mohrs et al.
patent: 5202336 (1993-04-01), Mohrs et al.
patent: 5212182 (1993-05-01), Musser et al.
patent: 5294622 (1994-03-01), Dreikorn et al.
Chemical Abstracts, vol. 97, 1982, p. 278, AN-18948c.
Chemical Abstracts, vol. 90, 1979, p. 136, AN-34849g.

Affiliated with

Also associated with

Rating

Bradykinin antagonist quinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bradykinin antagonist quinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin antagonist quinolines will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-57689